₃Mark Cook

Summary for 2004 [at-glance overview of Mark Cook work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Mark Cook. According to available data, in 2004 Mark Cook published at least 3 articles. This work was completed in collaboration with several authors including Graham, Janet and Hitchcock, Alison. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that Mark Cook professional interests are focused around "teratogenicity results australian", "dose human teratogenicity" and "register anti-epileptic drugs". These might also be referred to as "results australian", "relationship sodium" or "teratogenicity results". Statistical analysis shows that Mark Cook's writing is likely to contains terms "pregnancy", "relationship", "drugs", "vpa", "results" and "dose".

The majority of Mark Cook articles are affiliated with Department of Medicine, The Australian Centre For Neuropharmacology, Raoul Wallenberg Centre, St. Vincent's Hospital, Fitzroy, 3065 Melbourne, Vic., Australia. Sadly, no email addresses were found for any of the affiliations.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Mark Cook]

Do you know Mark Cook who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Mark Cook]

₄₄Cook, M

Year 2004 Charts [Mark Cook frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Mark Cook publication and funding history for the range of years]

Mark Cook Coauthors (5) [all coauthors with the number of joint publications]

2

2

2

1

1

Other [context-specific ads]

Affiliations (1) [condensed summary of the Mark Cook affiliations, the leading number and the color conveys importance]

₁Department of Medicine, The Australian Centre For Neuropharmacology, Raoul Wallenberg Centre, St. Vincent's Hospital, Fitzroy, 3065 Melbourne, Vic., Australia.

Key Opinion Leader In [Mark Cook is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (24) [keywords assigned to Mark Cook articles by PubMed, the leading number and the color conveys importance]

₂Humans | ₂Epilepsy | ₁Evidence-Based Medicine | ₁Risk Factors | ₁Valproic Acid | ₁Drug Therapy, Combination | ₁Infant, Newborn | ₁Female | ₁Triazines | ₁Quality Assurance, Health Care | ₁Dissent and Disputes | ₁Anticonvulsants | ₁Pregnancy | ₁Pregnancy Complications | ₁Consensus | ₁Registries | ₁Abnormalities, Drug-Induced | ₁Pregnancy Outcome | ₁Prospective Studies | ₁Australia | ₁Randomized Controlled Trials as Topic | ₁Policy Making | ₁Health Services Administration | ₁Retrospective Studies

Mark Cook Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Mark Cook might be a good expert witness on these terms]

₅pregnancy | ₃relationship | ₃drugs | ₃vpa | ₃results | ₃dose | ₃australian | ₂teratogenicity | ₂valproate | ₂register | ₂human | ₂sodium | ₂critical | ₂anti-epileptic | ₂doses | ₁formula | ₁significantly | ₁registry | ₁associated | ₁conclusions | ₁taking | ₁trimester | ₁antiepileptic | ₁women | ₁experience-based | ₁text | ₁limit | ₁medicine | ₁mg | ₁fm | ₁dose-effect | ₁possible
₂results australian | ₂relationship sodium | ₂teratogenicity results | ₂critical relationship | ₂sodium valproate | ₂human teratogenicity | ₂australian register | ₂register anti-epileptic | ₂valproate dose | ₂dose human | ₂anti-epileptic drugs | ₂drugs pregnancy | ₁drugs results | ₁doses aeds | ₁medicine experience-based | ₁consensus mg | ₁limit possible | ₁vpa trimester | ₁significantly greater | ₁formula text | ₁aeds critical | ₁dose vpa | ₁pregnancy registry | ₁vpa associated | ₁associated significantly | ₁higher doses | ₁trimester pregnancy | ₁vpa pregnancy | ₁results highlight | ₁evidence-based | ₁experience-based practice--clash | ₁australian
₂teratogenicity results australian | ₂dose human teratogenicity | ₂register anti-epileptic drugs | ₂human teratogenicity results | ₂relationship sodium valproate | ₂australian register anti-epileptic | ₂anti-epileptic drugs pregnancy | ₂valproate dose human | ₂results australian register | ₂sodium valproate dose | ₂critical relationship sodium | ₁relationship fm exposure | ₁limit possible dose | ₁pregnancy critical relationship | ₁dose vpa pregnancy | ₁significantly greater risk | ₁australian pregnancy registry | ₁trimester pregnancy higher | ₁pregnancy higher doses | ₁practice--clash consensus mg | ₁medicine experience-based practice--clash | ₁vpa pregnancy critical | ₁registry women taking | ₁aeds critical relationship | ₁evidence-based medicine experience-based | ₁associated significantly greater | ₁taking antiepileptic drugs | ₁vpa trimester pregnancy | ₁experience-based practice--clash consensus | ₁evidence-based | ₁australian | ₁higher doses vpa

Reader's Comments (0) [comments posted by readers of Mark Cook profile]